Evidence map›Paper›PMID 30102568›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Loss of HDAC6 alters gut microbiota and worsens obesity.

Arnon D Lieber, Ulf H Beier, Haiyan Xiao, Benjamin J Wilkins, Jing Jiao, Xinmin S Li, Rebecca C Schugar, Christopher M Strauch, Zeneng Wang, J Mark Brown and 6 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. The histone deacetylase family in health and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Energy metabolism in health and diseases.Signal transduction and targeted therapy · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Assessment ofFrontiers in nutrition · 2023
    Article
  15. Abnormal intestinal milieu in posttraumatic stress disorder is not impacted by treatment that improves symptoms.American journal of physiology. Gastrointestinal and liver physiology · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Epigenetic regulation of energy metabolism in obesity.Journal of molecular cell biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Arnon D LieberDepartment of Medicine New York University School of Medicine (NYUSM), New York, New York, USA.
Ulf H BeierDivision of Nephrology, Department of Pediatrics University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Haiyan XiaoDivision of Nephrology, Department of Pediatrics University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Benjamin J WilkinsDivision of Anatomic Pathology, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jing JiaoDivision of Nephrology, Department of Pediatrics University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Xinmin S LiDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Rebecca C SchugarDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Christopher M StrauchDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Zeneng WangDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
J Mark BrownDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Stanley L HazenDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Nicholas A BokulichDepartment of Medicine New York University School of Medicine (NYUSM), New York, New York, USA.
Kelly V RugglesApplied Bioinformatics Laboratories, New York University School of Medicine (NYUSM), New York, New York, USA.
Tatiana AkimovaDivision of Transplant Immunology, Department of Pathology and Laboratory Medicine, Biesecker Center for Pediatric Liver Disease, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Wayne W HancockDivision of Transplant Immunology, Department of Pathology and Laboratory Medicine, Biesecker Center for Pediatric Liver Disease, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Martin J BlaserDepartment of Medicine New York University School of Medicine (NYUSM), New York, New York, USA.
Cleveland Clinic Lerner College of Medicine · USUniversity of Pennsylvania · USNew York University · USVA NY Harbor Healthcare System · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
Targeting 15-PGDH in Colon Cancer Prognosis, Prediction, Treatment and PreventionP50CA150964 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARKOWITZ, SANFORD D. · 2011 to 2022
$24.6M
Disappearing gastrointestinal microbiota in epidemic obesity.R01DK090989 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BLASER, MARTIN J · 2010 to 2015
$7.4M
Transgenic and mutant animalP01AI073489 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI KATSUMATA, MAKOTO · 2008 to 2012
$7.1M
Microbial, immune, metabolic perturbations by antibiotics (MIME study)U01AI122285 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI MARTIN J BLASER, Steven M Holland · 2016 to 2026
$5.2M
Targeting Sirtuin-1 to enhance Foxp3+ regulatory T-cell functionK08AI095353 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI BEIER, ULF · 2011 to 2015
$650k
ANTI-INFLAMMATORY EFFECTS OF TARGETING THE HDAC6/HSP90 PATHWAYR56AI095276 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI HANCOCK, WAYNE WILLIAM · 2011 to 2011
$209k
NCI NIH HHS P30 CA016087NCI NIH HHS P50 CA150964NIAID NIH HHS K08 AI095353NIAID NIH HHS P01 AI073489NIAID NIH HHS R56 AI095276NIAID NIH HHS U01 AI122285NIDDK NIH HHS R01 DK090989
6 · The paper itself

Abstract

Alterations in gut microbiota are known to affect intestinal inflammation and obesity. Antibiotic treatment can affect weight gain by elimination of histone deacetylase (HDAC) inhibitor-producing microbes, which are anti-inflammatory by augmenting regulatory T (T

Indexed as

Gastrointestinal MicrobiomeAnimalsBacteroidesDiet, High-FatFatty LiverFecesGerm-Free LifeHistone Deacetylase 6HyperlipidemiasLactobacillusMaleMesenteryMiceMice, Inbred C57BLMice, KnockoutObesityHdac6 protein, mouseHistone Deacetylase 6HDACinflammationmicrobiomeT-regulatory cells

Identifiers

PMID30102568
PMCPMC6355060
OpenAlexW2885802537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.